Donepezil for Alzheimer's disease
34 results
1 - 34
Donepezil for dementia due to Alzheimer's disease New search for studies and content updated (conclusions changed)
Donepezil for Alzheimer’s disease - Cholinesterase inhibitors for Alzheimer's disease: Cochrane systematic review
- Donepezil for dementia in people with Down syndrome New
- Donepezil for vascular cognitive impairment: Cochrane systematic review
- Memantine combined with donepezil in Alzheimer's disease
- Donepezil for vascular cognitive impairment
Continuing donepezil as dementia progresses is not helpful (DOMINO)- Alzheimer's disease
- Donepezil for mild cognitive impairment: Cochrane systematic review
- Drug treatments for obstructive sleep apnoea
- Cholinesterase inhibitors for dementia
- Drug therapy for obstructive sleep apnoea in adults: Cochrane systematic review
- Pharmacological interventions for cognitive decline in people with Down syndrome: Cochrane systematic review
- Statins for the treatment of dementia New search for studies and content updated (no change to conclusions)
- Treatment of a patient with memory disease
- Cholinesterase inhibitors for Parkinson's disease dementia
- Parkinson's disease dementia and dementia with Lewy bodies
- Dementia treatments minimally effective
- Some drugs slightly improve cognition in people with dementia; effects on behavioral or psychological symptoms remain unclear
- Pharmacological interventions for apathy in Alzheimer's disease Edited (no change to conclusions), comment added to review
- Cholinergic medication for antipsychotic‐induced tardive dyskinesia New search for studies and content updated (no change to conclusions)
- Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease: Cochrane systematic review
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review